Bivasave 250mg Injection- 1
Item requires a valid prescription
Manufactured By Abbott
Composition Bivalirudin (250mg)
Package Size ( 1 Injection in a vial )
100% Authentic
Products
Free Delivery
COD
Easy Returns &
Cancellation
Pharmacies (1)
MRP Rs 7.95
Description:
Bivasave 250mg Injection- 1 is used to prevent the formation of blood clots in adults during certain surgical procedures and therapies. This medicine is given along with aspirin and is not recommended for use in patients with acute coronary syndromes (ACS) who are not undergoing PCI (Percutaneous Coronary Intervention) or PTCA (Percutaneous Transluminal Coronary Angioplasty) as the safety and efficacy are not clinically established.
Uses / Indications:
Treatment and prevention of Blood clots
Interactions / Warnings:
Interaction with alcohol is unknown. Please consult your doctor.
Pregnancy interaction:
Expert advice:
Side Effects:
How to use:
How it works:
Faq for medicine:
A: Bivasave is used to prevent the formation of blood clots in patients with chest pain due to heart disease (acute coronary syndromes - ACS) and who have undergone procedures to treat blockages in their blood vessels (angioplasty and/or percutaneous coronary intervention - PCI)
Q: How is Bivasave metabolized?
A: Bivasave is metabolized by enzymes called as proteases, which break down Bivasave into inactive products
Q: What class is Bivasave?
A: Bivasave belongs to a class of drugs called parenteral anticoagulant, i.e. it is a blood-thinning agent that prevents formation of blood clots, and is administered by injection
Q: Does Bivasave affect International Normalized Ratio (INR)?
A: Yes, Bivasave can cause increase in INR, which is a laboratory test to detect the ability of blood to clot. Increased INR indicates decreased clotting of blood
Q: Does Bivasave affect activated clotting time (ACT)?
A: Bivasave increases the ACT, indicating reduced blood clotting ability
Q: How does Bivasave work?
A: Bivasave acts by preventing the formation of clot in the blood vessels.
Medicine interaction:
Available Substitutes
